

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:


Renalytix PLC - London-based diagnostics company focused on kidney health - Completes a USD8.8 million equity subscription and a USD21.2 million subsc...


(Sharecast News) - Renalytix announced the completion of a $30m (£23.06m) financing package on Friday, to support its growth and for general work...


(Sharecast News) - Artificial intelligence (AI)-focussed diagnostics company Renalytix reported first-half revenue of $1.3m (£0.99m) in its first...


Renalytix PLC - London-based diagnostics company focused on kidney health - Reports a widened pretax loss of USD26.8 million for the six months to Dec...


(Sharecast News) - Renalytix announced on Tuesday that it has reached an enrollment milestone for its kidney disease and diabetes medicine platform.


(Sharecast News) - Renalytix announced the launch of the new 'myIntelX' provider access portal on Wednesday, to provide access for United States physi...


(Alliance News) - Renalytix PLC shares soared on Wednesday after the company said it launched its new provider access portal myIntelX in the UK.